Pharmaceutical discount agreements with joining option
Original notice title
Germany – Pharmaceutical products – Arzneimittelrabattverträge mit Beitrittsoption
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
20 / 100
Risk factors
Critical information such as estimated value, award criteria, and eligibility requirements are not provided in the noti...
The notice disclaims applicability of EU procurement directives, which may reduce legal recourse in case of disputes.
No procurement documents available
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Sep 2027
- Supply of pharmaceutical products containing the active ingredient Lercanidipin.
- Framework agreement with a joining option (Beitrittsoption), allowing other entities to join.
Show full summary
This is a voluntary transparency notice for a framework agreement with a joining option for pharmaceutical products, specifically the active ingredient Lercanidipin, issued by BARMER. The framework runs from 1 May 2025 to 30 September 2027, with a possible extension of 3 months. The notice explicitly states it is not a public procurement under EU Directive 2014/24/EU. Submission deadline is 1 May 2027 at 10:35 CEST. No estimated value or award criteria are provided.
Risks
Critical information such as estimated value, award criteria, and eligibility requirements are not provided in the noti...
The notice disclaims applicability of EU procurement directives, which may reduce legal recourse in case of disputes.
No procurement documents available
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- The notice is not a public procurement under EU Directive 2014/24/EU; it is a voluntary transparency notice.
- Multiple tenders are allowed (up to 999).
- Variants are not allowed.
Buyer
Location
Wuppertal, DEU
Website
Identifier
992-80322-57
Activity
Health
Lots (1)
LOT-0000
Pharmaceutical discount agreements with joining option
Framework agreement for the supply of pharmaceutical products containing the active ingredient Lercanidipin. The framework includes a one-time extension option of 3 months until 30 September 2027. Details are available in the procurement documents.
Duration
Category
Deadline
Award details
Wirkstoff Lercanidipin, Einzelheiten können den Unterlagen entnommen werden. Die BARMER hat eine einmalige Verlängerungsoption um 3 Monate bis zum 30.09.2027.
Value note
Show original TED data
Original lot title
Arzneimittelrabattverträge mit Beitrittsoption
Original TED description
Wirkstoff Lercanidipin, Einzelheiten können den Unterlagen entnommen werden. Die BARMER hat eine einmalige Verlängerungsoption um 3 Monate bis zum 30.09.2027.
Procurement Details
- Publication date
- 26 Mar 2025
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 197516-2025
Documents (1)
Similar tenders
Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)
Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
20 / 100
Risk factors
Critical information such as estimated value, award criteria, and eligibility requirements are not provided in the noti...
The notice disclaims applicability of EU procurement directives, which may reduce legal recourse in case of disputes.
No procurement documents available
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications